UK markets closed

Synmosa Biopharma Corporation (4114.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
39.10+0.35 (+0.90%)
At close: 01:30PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 14.91B
Enterprise value 15.70B
Trailing P/E 24.07
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.79
Price/book (mrq)2.22
Enterprise value/revenue 3.05
Enterprise value/EBITDA 15.56

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 3-10.03%
S&P500 52-week change 322.38%
52-week high 343.89
52-week low 334.90
50-day moving average 338.83
200-day moving average 338.27

Share statistics

Avg vol (3-month) 31.2M
Avg vol (10-day) 3791.9k
Shares outstanding 5384.86M
Implied shares outstanding 6384.86M
Float 8329.41M
% held by insiders 118.92%
% held by institutions 14.74%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.56
Forward annual dividend yield 41.43%
Trailing annual dividend rate 30.60
Trailing annual dividend yield 31.55%
5-year average dividend yield 40.69
Payout ratio 434.62%
Dividend date 3N/A
Ex-dividend date 408 Aug 2023
Last split factor 21093310.5:1000000
Last split date 308 Aug 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 11.57%
Operating margin (ttm)12.37%

Management effectiveness

Return on assets (ttm)3.36%
Return on equity (ttm)5.49%

Income statement

Revenue (ttm)5.14B
Revenue per share (ttm)13.92
Quarterly revenue growth (yoy)6.50%
Gross profit (ttm)N/A
EBITDA 927.91M
Net income avi to common (ttm)594.83M
Diluted EPS (ttm)1.61
Quarterly earnings growth (yoy)6.40%

Balance sheet

Total cash (mrq)1.65B
Total cash per share (mrq)4.32
Total debt (mrq)2.43B
Total debt/equity (mrq)30.03%
Current ratio (mrq)2.14
Book value per share (mrq)17.56

Cash flow statement

Operating cash flow (ttm)511.93M
Levered free cash flow (ttm)148.45M